Management des Vestibularisschwannoms

Zusammenfassung

Primäres Ziel der Behandlungsstrategie von Vestibularisschwannomen ist der Erhalt bzw. die Optimierung der Lebensqualität unter bestmöglicher Erhaltung der Nervenfunktionen. Einfluss auf das Management von Vestibularisschwannomen haben in erster Linie Tumorgröße, Tumorlage, Wachstumstendenz, Alter und Komorbiditäten sowie audiovestibuläre Symptome, d. h. Gleichgewichts- und Hörstörungen.

Abstract

Vestibular schwannomas are benign neoplasms originating from the Schwann cells of the vestibular vestibular nerve of the vestibulocochlear nerve, and rarely from the pars cochlearis. These are tumors that are in contact with the nerve but do not bind the fibers. Benign neoplasms of the Schwann cells of the auditory and equilibrium nerves can also occur primarily in the inner ear and are referred to as intralabyrinthine schwannomas (ILS). Vestibular schwannomas represent 6–7 % of all intracranial and 90 % of cerebellopontine angle tumors. Bilateral occurrence occurs in < 5 % of cases, and then corresponds to type 2 neurofibromatosis. The first symptom is often a unilateral hearing loss. It may then lead to balance disorders, tinnitus, facial paralysis and other impairments. Diagnosis is audiological, vestibular and imaging. Magnetic resonance imaging currently represents the gold standard. Management chooses between an observational strategy and surgery, depending on tumor size, age, and other factors. The possible access routes offer different advantages and disadvantages; the potential complications include the liquorrhoea. Radiation therapy is possible in special cases, and drug therapies are also being tested. In the rehabilitation of the hearing function, in addition to a CROS or BICROS restoration, the cochlear implant has been used with good success. The impact on quality of life is largely determined by hearing impairment, balance disorders, tinnitus, and possibly headache, which must be considered in patient consultation and long-term care.

Schlüsselwörter

Vestibularisschwannom - Akustikusneurinom - Schwindel - Tinnitus - Hörminderung

Key words

Vestibular schwannoma - acoustic neuroma - dizziness - tinnitus - hearing loss

Fußnote

^* C. Schulz und S. Plontke haben gleichberechtigt zum Artikel beigetragen

• Literatur

• 1 Brodhun M, Stahn V, Harder A. Pathogenese und Molekularpathologie des Vestibularisschwannoms. HNO 2017; 65: 362-372 doi:10.1007/s00106–016–0201–3
• 2 Neurofibromatosis, Conference Statement, National Institute of Health Consensus Development Conference. Arch Neurol 1988; 45: 575-578
• 3 Beenstock M. Predicting the Stability and Growth of Acoustic Neuromas. Otol Neurotol 2002; 23: 542-549
• 4 Tieleman A, Casselman JW, Somers T. et al. Imaging of intralabyrinthine schwannomas: a retrospective study of 52 cases with emphasis on lesion growth. Am J Neuroradiol 2008; 29: 898-905 doi:10.3174/ajnr.A1026
• 5 Plontke SK, Rahne T, Pfister M. et al. Intralabyrinthäre Schwannome: Chirurgisches Management und Hörrehabilitation mit Cochleaimplantaten. HNO 2017; 65: 419-433 doi:10.1007/s00106–017–0361–9
• 6 Plontke SK, Rahne T, Kösling S. Hörsturz mit Surditas, Schwindel und Tinnitus – eine 12-jährige Odyssee. Laryngorhinootologie 2018; 97: 490-492 doi:10.1055/s-0044–100517
• 7 Plontke SK. Diagnostik und Therapie des Hörsturzes. Laryngorhinootologie 2017; 96: 103-122 doi:10.1055/s-0042–122385
• 8 Waterval J, Kania R, Somers T. EAONO Position Statement on Vestibular Schwannoma: Imaging Assessment. What are the Indications for Performing a Screening MRI Scan for a Potential Vestibular Schwannoma?. J Int Adv Otol 2018; 14: 95-99 doi:10.5152/iao.2018.5364
• 9 Breivik CN, Nilsen RM, Myrseth E. et al. Working disability in Norwegian patients with vestibular schwannoma: vertigo predicts future dependence. World Neurosurg 2013; 80: e301-e305
• 10 Jerin C, Krause E, Ertl-Wagner B. et al. Klinische Eigenschaften von „delayed endolymphatic hydrops“ und intralabyrintharem Schwannom: Eine bildgebungsbasierte komparative Fallserie. HNO 2016; 64: 911-916
• 11 Rosahl S, Bohr C, Lell M. et al. Diagnostik und Therapie des Vestibularisschwannoms – eine interdisziplinare Herausforderung. Laryngorhinootologie 2017; 96: 152-182
• 12 Wilcke O. Differentialdiagnose der Tumoren im Kleinhirnbrückenwinkel. Acta Neurochir 1973; 28: 305-313
• 13 Baljić I, Winkler A, Schmidt T. et al. Untersuchungen zur perzeptiven Äquivalenz der Testlisten im Freiburger Einsilbertest. HNO 2016; 64: 572-583 doi:10.1007/s00106–016–0192–0
• 14 Müller J, Plontke SK, Rahne T. [Speech audiometric outcome parameters in clinical trials on hearing improvement]. HNO 03/2017; 65 (03) 211-218 doi: 10.1007/s00106–016–0298–4
• 15 Schmidt T, Baljić I. Untersuchung zum Trainingseffekt des Freiburger Einsilbertests. HNO 2016; 64: 584-588 doi:10.1007/s00106–016–0184–0
• 16 Rafique I, Wennervaldt K, Melchiors J. et al. Auditory brainstem response – a valid and cost-effective screening tool for vestibular schwannoma?. Acta Otolaryngol 2016; 136: 660-662 doi:10.3109/00016489.2016.1157726
• 17 Baljić I, Börner-Lünser E, Eßer D. et al. Frühe akustisch evozierte Potenziale bei Patienten mit „kleinem“ Vestibularisschwannom. HNO 2017; 65: 741-750 doi:10.1007/s00106–016–0261–4
• 18 Don M, Masuda A, Nelson R. et al. Successful detection of small acoustic tumors using the stacked derived-band auditory brain stem response amplitude. Am J Otol 1997; 18: 608-21
• 19 Blödow A, Helbig R, Wichmann N. et al. Video-Kopfimpulstest oder thermische Prüfung? Zeitgemässe Funktionsdiagnostik des Vestibularisschwannoms. HNO 2013; 61: 781-785
• 20 Rahne T, Plößl S, Plontke SK. et al. Präoperative Bestimmung des Ursprungsnervs von Vestibularisschwannomen. HNO 2017; 65: 966-972
• 21 Kösling S, Bootz F. Hrsg. Bildgebung HNO-Heilkunde. 2. Aufl.. Heidelberg: Springer; 2015. ISBN: 9783642451324
• 22 Kösling S. Moderne Schläfenbeinbildgebung. HNO 2017; 65: 462-471 doi:10.1007/s00106–016–0263–2
• 23 Strasilla C, Sychra V. Bildgebende Diagnostik des Vestibularisschwannoms. HNO 2017; 65: 373-380 doi:10.1007/s00106–016–0227–6
• 24 Stellungnahmen und Empfehlungen der AG Kopf-Hals-Diagnostik in der Deutschen Röntgengesellschaft zur MRT des Schläfenbeins. Im Internet: www.ag-kopf-hals.drg.de/de-DE/295/stellungnahmen-und-empfehlungen/
• 25 Rahne R, Hocke T, Strauss C. et al. Perioperative recording of cochlear implant evoked peripheral responses in a patient with neurofibromatosis 2 after removal of the intralabyrinthine portion of a vestibular schwannoma. Otol Neurotol. 2018 in press
• 26 Kania R, Vérillaud B, Camous D. et al. EAONO position statement on Vestibular Schwannoma: Imaging Assessment Question: How should growth of Vestibular Schwannoma be defined?. J Int Adv Otol 2018; 14: 90-94 doi:10.5152/iao.2018.5360
• 27 Wu H, Zhang L, Han D. et al. Summary and consensus in 7th International Conference on acoustic neuroma: An update for the management of sporadic acoustic neuromas. World J Otorhinolaryngol Head Neck Surg 2016; 2: 234-239 doi:10.1016/j.wjorl.2016.10.002
• 28 Koos WT, Day JD, Matula C. et al. Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg 1998; 88: 506-12
• 29 Kirchmann M, Karnov K, Hansen S. et al. Ten-Year Follow-up on Tumor Growth and Hearing in Patients Observed With an Intracanalicular Vestibular Schwannoma. Neurosurgery 2017; 80: 49-56 doi:10.1227/NEU.0000000000001414
• 30 Somers T, Kania R, Waterval J. et al. What is the Required Frequency of MRI Scanning in the Wait and Scan Management?. J Int Adv Otol 2018; 14: 85-89 doi:10.5152/iao.2018.5348
• 31 Rosahl S, Eßer D. Chirurgische Techniken zur Behandlung des Vestibularisschwannoms. HNO 2017; 65: 395-403 doi:10.1007/s00106–017–0353–9
• 32 Minovi A, Mangold R, Kollert M. et al. [Functional results, cognitive and effective quality of life disturbances after trans-temporal resection of acoustic neuroma]. Laryngorhinootologie 2005; 84: 915-920
• 33 Schick B, Greess H, Gill S. et al. Magnetic resonance imaging and neuropsychological testing after middle fossa vestibular schwannoma surgery. Otol Neurotol 2008; 29: 39-45
• 34 Iacoangeli M, Salvinelli F, Di Rienzo A. et al. Microsurgical endoscopy-assisted presigmoid retrolabyrinthine approach as a minimally invasive surgical option for the treatment of medium to large vestibular schwannomas. Acta Neurochir (Wien) 2013; 155: 663-670
• 35 Schwager K. [Acoustic neuroma (vestibular schwannoma) therapy from an oto-rhino-laryngological perspective]. HNO 2011; 59: 22 24–30. doi:10.1007/s00106–010–2190-y
• 36 Marchioni D, Camer M, Rubini A. et al. The Fully Endoscopic Acoustic Neuroma Surgery. Otolaryngol Clin North Am 2016; 49: 1227-1236 doi:10.1016/j.otc.2016.05.014
• 37 Magnusson M, Kahlon B, Karlberg M. et al. Preoperative vestibular ablation with gentamicin and vestibular ‘prehab’ enhance postoperative recovery after surgery for pontine angle tumours – first report. Acta Otolaryngol 2007; 127: 1236-1240
• 38 Tjernström F, Fransson PA, Kahlon B. et al. PREHAB vs. REHAB – presurgical treatment in vestibular schwannoma surgery enhances recovery of postural control better than postoperative rehabilitation: Retrospective case series. J Vestib Res 2018; 27: 313-325 doi:10.3233/VES-170626
• 39 Ansari SF, Terry C, Cohen-Gadol AA. Surgery for vestibular schwannomas: a systematic review of complications by approach. Neurosurg Focus 2012; 33: E14 doi:10.3171/2012.6.FOCUS12163
• 40 Sughrue ME, Yang I, Aranda D. et al. Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg 2011; 114: 367-374 doi:10.3171/2009.10.JNS091203
• 41 Crowson MG, Cunningham III CD, Moses H. et al. Preoperative lumbar drain use during acoustic neuroma surgery and effect on CSF leak incidence. Ann Otol Rhinol Laryngol 2016; 125: 63-68
• 42 Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumor resections. Neurosurgery 1997; 40: 248-260 discussion 260–262
• 43 Rampp S, Rahne T, Plontke SK. et al. Intraoperatives Monitoring des N. cochlearis bei Eingriffen im Kleinhirnbrückenwinkel. HNO 2017; 65: 413-418 doi:10.1007/s00106–016–0262–3
• 44 Prell J, Strauss C, Plontke SK. et al. Intraoperative Funktionsüberwachung. des N. facialis. Operationen an Vestibularisschwannomen. HNO 2017; 65: 404-412 doi:10.1007/s00106–017–0340–1
• 45 Scheller C, Herzfeld E, Strauss C. Medikamentöse Neuroprotektion in der Vestibularisschwannomchirurgie. HNO 2017; 65: 714-718 doi:10.1007/s00106–017–0386–0
• 46 Gjurić M, Wigand ME, Wolf SR. Enlarged middle fossa vestibular schwannoma surgery: experience with 735 cases. Otol Neurotol 2001; 22: 223-230 discussion 230–231
• 47 Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): the facial nerve – preservation and restitution of function. Neurosurgery 1997; 40: 684-694 discussion 694–695
• 48 Tveiten OV, Carlson ML, Goplen F. et al. Long-term Auditory Symptoms in Patients With Sporadic Vestibular Schwannoma: An International Cross-Sectional Study. Neurosurgery 2015; 77: 218-227 discussion 227
• 49 Scheich M, Ehrmann-Müller D, Shehata-Dieler W. et al. Hörergebnisse nach transtemporaler Resektion kleiner (T1/T2) Akustikusneurinome. HNO 2017; 65: 751-757 doi:10.1007/s00106–016–0228–5
• 50 Samii M, Gerganov V, Samii A. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg 2006; 105: 527-535
• 51 Combs SE, Welzel T, Kessel K. et al. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients’ self-reported outcome. Radiother Oncol 2013; 106: 175-80 doi:10.1016/j.radonc.2012.12.004
• 52 Hayhurst C, Zadeh G. Tumor pseudoprogression following radiosurgery for vestibular schwannoma. Neuro Oncol 2012; 14: 87-92 doi:10.1093/neuonc/nor171
• 53 Seferis C, Torrens M, Paraskevopoulou C. et al. Malignant transformation in vestibular schwannoma: report of a single case, literature search, and debate. J Neurosurg 2014; (Suppl. 121) 160-166 doi:10.3171/2014.7.GKS141311
• 54 Simmermacher S, Vordermark D, Kegel T. et al. Malignisierung eines Vestibularisschwannoms 13 Jahre nach Bestrahlung. HNO 2017; 65: 766-770
• 55 Mautner VF, Nguyen R, Kutta H. et al. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 2010; 12: 14-18
• 56 Plotkin SR, Stemmer-Rachamimov AO, Barker FG. et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009; 361: 358-367
• 57 Kandathil CK, Dilwali S, Wu CC. et al. Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo. Otol Neurotol 2014; 35: 353-357
• 58 Van Abel KM, Carlson ML, Link MJ. et al. Primary inner ear schwannomas: a case series and systematic review of the literature. Laryngoscope 2013; 123: 1957-1966 doi:10.1002/lary.23928
• 59 Plontke S, Kösling S, Pazaitis N. et al. Intracochleäres Schwannom: Tumorentfernung über subtotale Cochleoektomie und partielle Rekonstruktion der cochleären Kapsel unter Erhalt der Bogengangsfunktion. HNO 2017; 65: 610-616 doi:10.1007/s00106–017–0347–7
• 60 Thielker J, Bendella H, Gaudin RA. et al. Chirurgie bei Läsionen des Nervus facialis. Laryngo-Rhino-Otol 2018; 97: 419-434 doi:10.1055/a-0588–6622
• 61 House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985; 93: 146-147
• 62 Schipper J, Kristin J, Volpert S. et al. Hörrehabilitation durch Cochlea-Implantation nach Vestibularisschwannom-Entfernung?. Laryngorhinootologie 2017; 96: 836-843 doi:10.1055/s-0043–119546
• 63 Bohr C, Müller S, Hornung J. et al. Hörrehabilitation mit Cochleaimplantaten nach translabyrinthärer Vestibularisschwannomresektion. HNO 2017; 65: 758-765 doi:10.1007/s00106–017–0404–2
• 64 Plontke SK, Kösling S, Rahne T. Cochlear Implantation After Partial or Subtotal Cochleoectomy for Intracochlear Schwannoma Removal – A Technical Report. Otol Neurotol 2018; 39: 365-371 doi:10.1097/MAO.0000000000001696
• 65 Grupe G, Wagner J, Hofmann S. et al. Häufigkeit und Komplikationen von MRT-Untersuchungen bei Cochlea-Implantat-Patienten. HNO 2016; 64: 156-162 doi:10.1007/s00106–016–0128–8
• 66 Todt I, Rademacher G, Mittmann P. et al. Postoperative Bildgebung des inneren Gehörgangs: Darstellung aktiver auditorischer Implantate. HNO 2017; 65: 735-740 doi:10.1007/s00106–016–0295–7
• 67 Kameda K, Shono T, Hashiguchi K. et al. Effect of tumor removal on tinnitus in patients with vestibular schwannoma. J Neurosurg 2010; 112: 152-157
• 68 Jastreboff PJ. Tinnitus retraining therapy. Br J Audiol 1999; 33: 68-70
• 69 Cima RF, Maes IH, Joore MA. et al. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet 2012; 379: 1951-1959
• 70 Brüggemann P, Otto J, Lorenz N. et al. Long-term changes in multimodal intensive tinnitus therapy: A 5year follow-up.. HNO 2018; 66: 205-211
• 71 Baumann I, Plinkert PK. Lebensqualität von Patienten mit Vestibularisschwannom. HNO 2017; 65: 719-723 doi:10.1007/s00106–017–0371–7
• 72 Glaas MF, Schäfer R, Jansen P. et al. Quality of Life After Translabyrinthine Vestibular Schwannoma Resection-Reliability of the German PANQOL Questionnaire. Otol Neurotol 2018; 39: e481-e488 doi:10.1097/MAO.0000000000001819
• 73 Carlson ML, Tveiten OV, Driscoll CL. et al. Risk factors and analysis of long term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study. J Neurosurg 2015; 123: 1276-1286
• 74 Gharabaghi A, Samii A, Koerbel A. et al. Preservation of function in vestibular schwannoma surgery. Neurosurgery 2007; 60 (01) (Suppl. 01) ONS124-ONS127
• 75 Hoth S, Baljić I. Aktuelle audiologische Diagnostik. Laryngo Rhino Otol 2017; 96: 4-42
• 76 Kennedy RJ, Shelton C, Salzman KL. et al. Intralabyrinthine schwannomas: diagnosis, management, and a new classification system. Otol Neurotol 2004; 25: 160-167
• 77 Rosahl S, Eßer D. Vestibularisschwannom – Management und mikrochirurgische Ergebnisse. HNO 2017; 65: 381-387 doi:10.1007/s00106–016–0252–5
• 78 Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg. 09/1995; 113 (03) 179-80
• 79 Dilwali S, Kao SY, Fujita T. et al. Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas. Transl Res. 07/2015; 166 (01) 1-11
• 80 Schaller B. Die Chirurgie des Kleinhirnbrückenwinkels. Teil 2: Spezielle Bemerkungen. HNO 2003; 51: 375-385